FDA NDC Directory · JSON-LD · Markdown

Carbidopa and levodopa

NDC 42291-467 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA074260
Dosage form / routeTABLET · ORAL
Active ingredientsCARBIDOPA (25 mg/1)
LEVODOPA (250 mg/1)
Marketing started20210406
Marketing ended20260531
Package count1

External sources

Source: openFDA. Public-domain (CC0).